By David Woods ([email protected]) While the Golden Age of the pharmaceutical industry is over, and its reputation similar to that of the tobacco and oil industries, there is hope at…
By Mary Gabb ([email protected]) Nowadays, healthcare is hotly debated, and not just for US presidential candidates. Virtually every western country is now grappling with the challenge of how to pay…
By Ruth Whittington ([email protected]) The World Healthcare Congress, held March 10 – 13 in Berlin, always provides interesting insights on the ways governments, clinicians, and healthcare providers perceive healthcare delivery.…
By David Woods ([email protected]) The pharmaceutical industry is too often blamed for the stratospheric costs of healthcare — particularly in the United States. Yet, according to a series of surveys…
By Mary Gabb ([email protected]) With all of the recent news about job cuts or outsourcing in the pharmaceutical industry, health economists maybe worried about their own employment, as the downturn…
By David Woods ([email protected]) With this the 26th issue of HOC, we are well overdue in featuring our energetic, globetrotting CEO of Rx Communications, Ruth Whittington. I can say this…
By David Woods ([email protected]) There has been much written lately about the perceived failings of the FDA. The Wall Street Journal claims that “the place is a mess,” and a…
By Mary Gabb ([email protected]) As health economics plays a more prominent role in medical research and public policy, participation in panel discussions – either in front of a live audience…
By David Woods ([email protected]) Dr. Patti Peeples: what a perfect name for the subject of HOC people! She tells me that the origin of the name is from Peebles, in…
By David Woods ([email protected]) The Wall Street Journal published an editorial last month titled “The Lancet’s Political Hit.” It described how that venerable medical journal had published a study exaggerating…